ArticleFrontiers in pharmacology2021

First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults.

Jingrui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.